IL27090A - 17-acetyl-13beta-ethyl-gon-4-en-3-one derivatives and process for the manufacture thereof - Google Patents
17-acetyl-13beta-ethyl-gon-4-en-3-one derivatives and process for the manufacture thereofInfo
- Publication number
- IL27090A IL27090A IL2709066A IL2709066A IL27090A IL 27090 A IL27090 A IL 27090A IL 2709066 A IL2709066 A IL 2709066A IL 2709066 A IL2709066 A IL 2709066A IL 27090 A IL27090 A IL 27090A
- Authority
- IL
- Israel
- Prior art keywords
- group
- carbonyl group
- formula
- ethyl
- compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 27
- 238000004519 manufacturing process Methods 0.000 title description 3
- IJLOEMVVXWXXJN-CXOMEWPSSA-N (8R,9S,10R,13S,14S)-17-acetyl-13-ethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one Chemical class C(C)(=O)C1CC[C@H]2[C@H]3[C@H](CC[C@]12CC)[C@H]1CCC(C=C1CC3)=O IJLOEMVVXWXXJN-CXOMEWPSSA-N 0.000 title 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 41
- 150000001875 compounds Chemical class 0.000 claims description 41
- -1 steroid compound Chemical class 0.000 claims description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 230000007062 hydrolysis Effects 0.000 claims description 13
- 238000006460 hydrolysis reaction Methods 0.000 claims description 13
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 10
- 230000003647 oxidation Effects 0.000 claims description 8
- 238000007254 oxidation reaction Methods 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000006239 protecting group Chemical group 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 101100393235 Caenorhabditis elegans gon-1 gene Proteins 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 64
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 36
- 239000000203 mixture Substances 0.000 description 29
- 239000000243 solution Substances 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
- 239000000047 product Substances 0.000 description 21
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 20
- 239000002253 acid Substances 0.000 description 20
- 238000000605 extraction Methods 0.000 description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- 239000007858 starting material Substances 0.000 description 14
- 238000010521 absorption reaction Methods 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- 238000002425 crystallisation Methods 0.000 description 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 8
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 8
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 7
- 229910052744 lithium Inorganic materials 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 125000004043 oxo group Chemical group O=* 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 238000006027 Birch reduction reaction Methods 0.000 description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 150000003431 steroids Chemical class 0.000 description 5
- 150000005671 trienes Chemical class 0.000 description 5
- 235000018185 Betula X alpestris Nutrition 0.000 description 4
- 235000018212 Betula X uliginosa Nutrition 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- GEVPUGOOGXGPIO-UHFFFAOYSA-N oxalic acid;dihydrate Chemical compound O.O.OC(=O)C(O)=O GEVPUGOOGXGPIO-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001072 progestational effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 238000006036 Oppenauer oxidation reaction Methods 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- JLFVIEQMRKMAIT-UHFFFAOYSA-N ac1l9mnz Chemical compound O.O.O JLFVIEQMRKMAIT-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 150000001993 dienes Chemical class 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 2
- 150000002081 enamines Chemical class 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000003270 steroid hormone Substances 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DOBUSJIVSSJEDA-UHFFFAOYSA-L 1,3-dioxa-2$l^{6}-thia-4-mercuracyclobutane 2,2-dioxide Chemical compound [Hg+2].[O-]S([O-])(=O)=O DOBUSJIVSSJEDA-UHFFFAOYSA-L 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- RATCNXGORMQXEW-UHFFFAOYSA-N aminourea;hydrazine Chemical class NN.NNC(N)=O RATCNXGORMQXEW-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- YOUGRGFIHBUKRS-UHFFFAOYSA-N benzyl(trimethyl)azanium Chemical compound C[N+](C)(C)CC1=CC=CC=C1 YOUGRGFIHBUKRS-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007256 debromination reaction Methods 0.000 description 1
- 238000007269 dehydrobromination reaction Methods 0.000 description 1
- 238000006704 dehydrohalogenation reaction Methods 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N ethyl ethylene Natural products CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 229940069016 go-dry Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 238000006197 hydroboration reaction Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- ZPIZRHAHXTZZPJ-UHFFFAOYSA-N methanol;propane Chemical compound OC.CCC ZPIZRHAHXTZZPJ-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229940053934 norethindrone Drugs 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- FZJCXIDLUFPGPP-UHFFFAOYSA-N propan-2-ol;toluene Chemical compound CC(C)O.CC1=CC=CC=C1 FZJCXIDLUFPGPP-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000005415 substituted alkoxy group Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Description
This invention having progestational or other steroid hormone activity which are intermediates the production of such steroid The invention also relates processes for producing the compounds and to pharmaceutical compositions tainin certain of The steroid compounds of the invention are those havin formula is a carbonyl or ketalised carbonyl and the hydrogen atoms H at positions 9 and 14 and the roup at on ring G are in the iguration and the hydrogen atom H at position 10 is cis o the ethyl and the at position 17 on ring D designates that the side chain is either cis or trans the compounds in which X is a hydroxymethylene or ketalised carbonyl group are intermediates which are oxidised or hydrolysed respectively to compounds in which X is a carbonyl group which have or other steroid hormone Thus has 10 times the progestational activity of progesterone and its isomer has progestational activity and an oral parenteral ratio of using standard test The invention also concerns processes for the production of steroid compounds having the formula in which a steroid compound of formula in which one or both of X and Z are hydroxymethylene any remaining X or Z group which is not such a group being a carbonyl group or in the case of X a ketalised carbonyl the dotted lines signify an ethylenic bond terminating at the the group at position is in either configuration and the configurations at positions d 14 are as defined is oxidised at one or both of the 3 and 20 a steroid compound of formula where X is a hydroxymethylene a carbonyl group a carbonyl group Y is a carbonyl group in conjunction with an ethylenic bond terminating at the or a protected carbonyl group in conjunction with unsaturation in rings A and B indicated by the dotted lines such that it is hydrolysable to a or one or both of X and Y being a protected carbonyl the group at 7 in either configuration and the configurations at positions and are as defined is hydrolysed to remove the protecting group or groups at one or both of the 3 and 20 a steroid compound of formula where the dotted lines signify the presence of an ethylenic bond at the or 5 group at position is in either configuration and the configurationsat position and are as defined is isomerised to shift the ethylenic bond to the or a steroid compound of formula in which Hal is a halogen preferably bromine or chlorine in the a or the and the group at position can be in either configuration and the configuration at positions 13 are as defined is dehydrohalogenated to introduce a when oxidation of a hydroxymethylene group X to a carbonyl reaction of a carbonyl group X with a ketalising hydrolysis of a protected ketalised carbonyl group X or a reduction of a carbonyl group X to a hydroxymethylene group and again where necessary isomerisation of an ethylenic bond at the or to the or of a chain to a The oxidation process is conveniently carried out using a conventional oxidising chromic acid or by the Oppenauer If the double bond in ring A is at the or 5 the oxidation should be carried out under conditions which are sufficiently acidic or basic to isomerise it to the Starting compounds of formula are readily made by standard procedures from known compounds to make a starting compound of formula where Z is a carbonyl group there may be hydrolysed a compound of formula where Z is a protected oxo group which in conjunction with uneaturation in rings A and B indicated by the dotted lines is hydrolysable by acid to a or a Z can be a single substituted or unsubstituted aliphatic hydrocarbon group or acyl group linked to ring A by nitrogen or sulphur in conjunction with two ethylenic one of which terminates at the and the other at the it can also be two substituted or unsubstituted aliphatic hydrocarbon groups can be joined linked to ring A by oxygen or sulphur in conjunction with a single ethylenic bond terminating at the Preferably the organic radical of Z is a wholly carbon Z can be and is preferably alkoxy example methoxy or or it can be a substituted alkoxy group example a or dihydroxy ropyloxy It can be an alkylthio group example ethylthio or an acyloxy group example or a disubstituted amino group example It can also be an alk dioxy group an ethylenedioxy or an or alkylene thiooxy Thus the starting compounds are exemplified by and enamines of the corresponding the thioketals or hemithioketals of or The hydrolysis is normally with acid but where the protecting group is an ester group it can additionally be hydrolysed by base and certain enamines can be hydrolysed under neutral or basic The unsaturation in ring A is such that hydrolysis removes the organic portion of the group Z and converts it and any ethylenic bond terminating at the position to an oxo Under sufficiently acid conditions or under basic conditions the ethylenic bond terminating at the if not already at the is rearranged to that Normally strong acids such as mineral hydrochloric acid or alkalies are used for this A weaker acid such as an organic acid oxalic can be used for the hydrolysis where the double bond is already at the or alternatively a double bond at the or can be isomerised to the during the oxidation step as mentioned Thus for it will be appreciated that mild hydrolysis of a for instance with a weak organic acid such as aqueous alcoholic oxalic acid at will give a which is readily isomerised to a with stronger acid treatment or with a such a 2 stage process is a well known chemical equivalent of the direct 1 stage hydrolysis under more vigorous acid conditions using a strong usually a mineral acid such as hydrochloric as with hydrochloric acid at Moreover a 1 side chain can be equilibrated by acid or base to give a mixture of predominantly together with some The concept of protecting an oxo or carbonyl group as a derivative such as those mentioned above and their removal to regenerate the oxo or carbonyl group is well known Steroid The earlier starting compounds can be prepared from British Patent by known For instance this can be by British Patent followed by conversion of the resulting by treatment with to give a dibromoacetyl group and debromination with zinc and acetic acid to give a for instance as shown in Example Such a compound can be subjected to Birch redustion for instance as shown is Example 1 to give a when there is simultaneous deacetoxylation and reduction at Alternatively deacetoxylation of the intermediate can be effected prior to Birch reduction by treatment with calcium in liquid ammonia to give a intermediate which can be subjected to Birch reduction as such to give a or can be ketalised and then subjected to Birch reduction to give a Alternatively the intermediate can be hydrated with mercuric sulphate to give a intermediate which in turn is hydrogenated to 17 the latter compound can be subjected to Birch reduction as mentioned Again in a further method of preparing the starting materials a is ethylated to give a e which is dehydrated to a intermediate and this is in turn hydrated by the hydroboration to give a as Such an intermediate can be submitted to Birch reduction and hydrolysed with to give a starting compound of formula The hydrolysis as above mentioned of a compound of structure gives a starting compound of structure where Z is a carbonyl group and X is a hydroxymethylene Starting compounds where Z is a group and X is a hydroxymethylene carbonyl or protected carbonyl group can be made by starting with a or or building up the side chain at position described above and then removing any protecting group by Referring now to the hydrolysis process the group Y in formula and its hydrolysis when it is a protected carbonyl group are exemplified in the same way as for the protected oxo group Z in formula The group X when a protected carbonyl group and its hydrolysis are similarly In the starting compounds can be prepared by known methods as by the general procedures outlined Starting compounds where X is a protected carbonyl group can readily be prepared from the corresponding where X is a carbonyl by forming the desired derivative and then converting the ring A end of the molecule to one having a group Y and unsaturation as described As an example a can be ethylated to give a e is dehydrated to a and this in turn is hydrated instance by the to give a latter can be oxidised to a acetyl compound the graup therein protected by being submitted to Birch and the group removed during subsequent hydrolysis with asid in accordance with the The process can be performed with a strong as a mineral acid hydrochloric acid in a suitable solvent such as or aqueous It also be by treatment with a base in a similar If the acidic or basic conditions are sufficiently strong not only is the ring A double but the side chain is epimerised to give a mixture from which both and can be Thus methanolic hydrochloric acid under reflux for causes the appearance of about from the Less vigorous acid conditions substantially avoid this epimerisation and more vigorous acid conditions are preferable if epimerisation is Similarly treatment of the with methanolic potassium hydroxide at for hours gives a mixture containing about of the but with more dilute alkali for a shorter time epimerisation is The compounds can be readily prepared by known methods as indicated For example a by Birch redustion of a corresponding or can be hydrolysed with a mild acid hydrolysing agent such as a weak organic acid in a lower alkanol to give the corresponding The latter may be for instance with chromic acid or by the Oppenauer method or using the acetic sulphoxide method to give the corresponding compound Oppenauer method will tend to epimerise any to the The dehydrohalogenation reaction is conveniently carried out in conventional mannerfor instance in the presence of a weak or insoluble base example a tertiary amine such as pyridine or collidine or an insoluble carbonate such as an or a basic salt as misiteate alkaline earth metal carbonate or lithium or in presence of a halide ion acceptor such as a boron or aluminium halide Dehydrobromination can also be effected by reaction with a carbonyl blocking agent such as a substituted hydrazine semicarbazide or followed by hydrolytic removal of the blocking See also Steroid Chapter The basic conditions used should be mild enough to avoid rearrangemeat of ring A by the Favo sky To prepare a conveniently the product of the process of the invention is epimerised using strongly acid or basic for instance as shown in Example The starting compounds can be readily prepared by catalytic hydrogenation of a to give a The oxo group can then be protected as a derivative group Steroid for instance as a hemithioketal thioketal or by reduction to a which can be converted to a A group if not present is then introduced and a side chain is built up by known methods as described above to give a Alternatively a latter compound can be prepared from norethisterone as shown in Example ethyl The is then halogenated by conventional procedures Djerassi to give the desired starting preferably using a quarternary ammonium or tertiary amine perbromide such as the ammonium trihalide reagent of Marquet et Chi and Using the latter procedures a protected particularly a enol acetate or enol can similarly be In the structural formulae to a continuous line connecting an atom or group to the tetracyclic nucleus has no configurational but is used solely to indicate the position in the nucleus to which the atom or group is Thus in these structures the and compounds are not separately as unless the product has been obtained by a synthesis which has included a resolution stage and for using the terminology of the Convention approved by Fieser and at page resolved having the 8β this and its antipode the with configuration will be present in equimolecular mixture or racemate one enantiomer being or dextrorotatory and the other In the Examples below such structures are designated as in accordance with the aforementioned Position is also an centre and for convenience and brevity in the foregoing passages on the preparation of starting configurations at this position have been referred to as or In such cases this is with reference to the having the without reference to the state of resolution of the compound referred to and an equivalent meaning is that a group designated is cis to the group at position and if designated is trans to that Preferably the starting material in a process of the invention is a resolved The invention particularly includes the having the group in the presence or absence of their it includes the resolved compounds and the forms in admixture with the corresponding especially racemic The also provides a pharmaceutical composition comprising a of formula I as aforementioned and a pharmacologically acceptable The pharmaceutical compositions of the invention can be formulated in liquid or solid for instance as dispersible and the like by combining them with conventional Such conventional carriers include magnesium carbonate or methyl sodium carboxymethyl low melting wax and cocoa flavouring suspending binders or tablet disintegrating agents can be Powders and tablets preferably contain 5 or 10 to of the active The active steroid can be formulated with an encapsulating material with or without other carriersβ Liquid preparations such as suspensions or emulsions can also be Such preparations include dispersions in a pharmaceutically acceptable liquid carrier such as arachis oil or sterile preferably containing a surface active agent such as fatty acid esters of polyhydroxy compounds sorbitan instance polyethylene oxide fatty acid esters such as Tween aqueous starch in sodium carboxymethyl cellulose aqueous propylene glycol Thus a propylene glycol solution can be used for parenteral injection by utilising natural or synthestic methyl cellulose or other suspending The composition can be in unit dose form in which the dose unit is for instance from to 20 of the active depending on the therapeutic use The unit dose form can be a packages composition packeted vials or ampoules or for example in the form of cachets or tablets or any A EXAMPLE 1 7 triene was shaken with acid and acetic anhydride until the solution was homogeneous and then allowed to stand at room temperature for 12 The reaction mixture was decomposed by stirring with water containing a little pyridine and extracted with The ethereal solutio was washed with 2N aqueous sodium dilute hydrochloric brine and dried The solvent was evaporated and the crystalline residue dissolved in benzene and filtered through a short column of The product was recrystallised from acetate to give the title Infrared absorption triene was dissolved in tertiary butanol and water and was The reaction mixture was allowed to stand for 15 then water was added and the mixture cooled to and allowed to stand for 3 The precipitated product was washed with aqueous methanol and dried to give the title in acetic acid water sodium acetate was heated with zinc dust for minutes with The mixture was filtered and the product precipitated from the filtrate by the addition of The mixture was filtered and the residue dried and recrystallised from ethyl acetate methanol to give the title Infrared absorption triene in dioxan was added to a stirred solution of lithium in liquid ammonia After 30 minutes methanol was added followed by lithium in small Addition of water and extraction with ether gave a gum which was refluxed for minutes with 4N hydrochloric acid in methanol Addition of water and extraction with ether gave a gum which was dissolved in acetone containing anhydrous magnesium sulphate and 8N chromic acid was added dropwise with swirling until the solution assumed a permanent Excess isopropanol was added and the solution evaporated almost to Addition of water and extraction with ether gave a gum which crystallised with Filtration through alumina with and recrystallisation of the product from ethyl acetate ether gave Infrared absorption EXAMPLE 2 A solution of in pyridine and phosphorus chloride was refluxed 2 hours then the cooled reaction mixture was cautiously poured onto The mixture was extracted with washed with hydrochloric sodium bicarbonate and The ethereal solution was evaporated and the residue recrystallised from ethanol to give the title compound 9 s A stream of diborane by the gradual addition of sodium borohydride 1 in diethyleneglycol dimethyl ether 00 to boron trifluoride etherate 105 in glycol dimethyl ether was passed through a solution of in dry tetrahydrofuran for 90 The mixture was allowed to stand for 16 hours and then cautiously decomposed by the addition of Sodium hydroxide 15 in water and hydrogen peroxide was added and the mixture refluxed with stirring for 1 The cooled solution was extracted with the ethereal solution washed with dried and evaporated and the residue recrystallised from acetonitrile to give the title compound Further purification gave a 8θ A solution of 1 in tetrahydrofuran was added to distilled liquid ammonia and lithium was added in small The mixture was stirred for 1 hour and then ethanol was added over a period of When the blue colour was most of the ammonia was evaporated and to water and acidified 6 with acetic The mixture was extracted with and the ethereal solution washed with aqueous sodium water and The ethereal solution was evaporated and the residue recrystallised from ethanol to give the title compound go infrared absorption peaks at 1 A mixture of go acid water and methanol was stirred at for 1 The precipitate was filtered and dried to give the title compound ultraviolet absorption peak at 242 infrared absorption peaks at From the mother liquor was obtained more material To a solution of drox in acetone was added 8N chromic acid over 5 minutes at The mixture was stirred at for then excess isopropanol and magnesium sulphate were and the mixture Benzene was added to the which was washed with aqueous sodium dried and The residue was recrystallised from hexane and dried to give the title product infrared absorption peaks at ultraviolet absorption maximum at 241 EXAMPLE 3 5β A solution of in dioxane was added to a solution of calcium liquid ammonia cc and the mixture stirred for a further 30 Ammonium chloride was the ammonia evaporated and water added and the precipitate dried and recrystallised from ethyl to yield the title compound infrared absorption peaks at 5 in methanol was stirred with potassium hydroxide 1 at for hours in an atmosphere of The mixture was diluted with with water and brine and Evaporation of the solvent gave a gum consisting of the title compound contaminated with starting material analysis of proton magnetic resonance spectrum and Reduction of triene equilibrium mixture described in the previous with lithium and ethanol in liquid ammonia followed by acid hydrolysis and chromic acid oxidation as described for 1 gave the title compound containing about of the magnetic resonance absorption of and of the former EXAMPLE 3 and 1 triene in acetone was treated with 8N chromic acid and the mixture allowed to stand at for 30 minutes Excess reagent was decomposed by the addition of and the mixture filtered through The filtrate was evaporated and the resultant gum crystallised from ethanol to give the first title compound Further purification gave a sample infrared absorption peak at This compound can be subjected to Birch hydrolysis with methanolic hydrochloric acid and oxidation with chromic acid in acetone as in Example 2 to give the same product EXAMPLE 5 ketal e 3 see Example in toluene and ethylene glycol was refluxed with acid for 18 hours with continuous removal of water0 Ether was added to the cooled solution which was washed with aqueous sodium brine and The solvent was removed to leave the title compound mixture of and as a having no carbonyl absorption in the The foregoing ethylene ketal in dioxan was added to a stirred solution of lithium in liquid ammonia After 30 methanol was added followed by lithium in small Addition of water and extraction with ether gave ethylene ketal as a gum This was stirred at for 1 hour with 10N hydrochloric acid 1 in methanol and water 1 Addition of water and extraction with ether gave a gum which was graphed on alumina and crystallised from ethyl acetate to give the title compound The infrared absorption and EXAMPLE 6 ethyl 5 10 diene Example was stirred in methanol containing water and oxalic acid dihydrate until the solid dissolved and was kept at room temperature for 1 The product was isolated by extraction with ether and crystallisation from methanol to give the title compound A solution of the foregoing in methanol containing oxalic acid dihydrate was stirred at room temperature for 1 Dilution with washing with saturated aqueous sodium water and stripping in vacuo gave a Recrystallisation methanol containing a drop of pyridine gave the title compound go no UV The foregoing 1 isopropoxide toluene and were refluxed under nitrogen for 3 The product was isolated by adding extraction with ether and evaporation to dryness to give the title compound in admixture with the as a solid as prepared above was refluxed for minutes chloric acid 10 in methanol The product was isolated by addition of extracted with chromatographed through a short column of alumina and crystallised from hexane to give The mother liquor residue was crystallised several times from to give the 6 2 EXAMPLE propane methanol and acid was refluxed for The solution was excess sodium bicarbonate was added and the mixture was poured into ice The product was isolated by extraction with benzene and crystallisation from methanol containing a trace of pyridine to give eth as a crystalline This was subjected to Oppenauer oxidation by the procedure of Example 6 to give after crystallisation from methanol containing a trace of pyridine e 5o86 250 This compound was sitrred at for 1 hour with 10N hydrochloric in methanol and water 1 Addition of ether alumina and crystallisation of the product from ethyl acetate gave 8 Similarly to Example 7 to in a minimum amount of refluxing methanol was added drops of Cooling to room temperature crystallisation of the product followed by Oppenauer oxidation gave This compound was hydrolysed by refluxing in methanol 10 and water containing acetic acid and sodium acetate for hours and then poured into extracted with and crystallised from to give the same ene go dry redistilled dimethylsulphoxide 10 and acetic anhydride were stirred at for The mixture was poured into potassium carbonate extracted with ether and crystallised from methanol containing a little pyridine to give This was treated with methanolic hydrochloric acid as in Example 6 to give EXAMPLE 10 diene Example was stirred in methanol containing water and oxalic acid dihydrate until the solid dissolved and was kept at room temperature for 1 The product was isolated by extraction with ether and crystallisation from methanol to give the title compound go IBs 1 dry redistilled dimethyl sulphoxide and acetic anhydride were stirred at for The mixture was poured into potassium carbonate extracted with ether and crystallised from methanol containing a little pyridine to give the crude title one was stirred at for 1 hour with 10N hydrochloric acid in methanol and water Addition of ether extraction and crystallisation from ethyl gave the title compound 1 EXAMPLE was dissolved in ethanol and added to a solution of sodium in ethanol The mixture was kept at for hour under The product was isolated by extraction with chromatography on alumina and crystallisation from ethyl to give one EXAMPLE 12 in 100 methanolic potassium hydroxide was kept under nitrogen at 2k After acidification and extraction with the product was passed through a short column of eluting with The fractions were evaporated and the residue was crystallised twice from to give The combined mother liquors were evaporated and the residue crystallised twice from to give 2 0 m 16 EXAMPLE hy 3 in ethanol was hydrogenated in the presence of palladium on charcoal until the uptake of hydrogen had ceasedo After filtration of the catalyst and evaporation of the the residue was crystallised from to afford the title ketal The previous title compound in toluene and ethylene glycol was refluxed with acid with continuous removal of Ether extraction then gave the title compound This compound is also prepared by catalytic hydrogenation as above of to give ketalisation as above to give the ethylene oxidation with chromium trioxide in acetone to give the and e on with ethyl ethylene ketal The previous title compound 1 in pyridine and phosphorus oxychloride was refluxed for 2 hours and the cooled reaction mixture poured onto Extraction with ether then gave the derivative which was treated in dry tetrahydrofuran 30 with pure The mixture was allowed to stand for hours and then cautiously decomposed by addition of Sodium hydroxide in water 120 and hydrogen peroxide 12 was added and the mixture was refluxed with stirring for 1 The cooled solution was extracted with ether and the residue crystallised from methanol to give the title and its 3 ketal The foregoing title compound 0 5 and phenyl ammonium tribromide et and 0 in tetrahydrofuran 10 were kept at for 16 hours0 The product was isolated by pouring the reaction mixture into sodium bicarbonate solution and extraction with ether to give the title compound ketal which the parent ketone awas isolated by treatment at for 5 hours in acetone 15 water 0 3 and acid 02 or treatment with N hydrochloric acid in methanol 20 containing water 1 for hours at and crystallisation from methanols The parent ketone was also obtained by similar of the starting compound and bromination in the same The bromination pyridinium reaction proceeds similarly using perbromide in pyridine at for 1 hour with removal of excess of reagent with sodium thiosulphate and isolation of the product by dilution with dilute acid in the to avoid and extraction with 2k The foregoing in acetone solution containing anhydrous magnesium was treated drop ise with 8N chromic acid with swirling until the solution assumed a permanent Excess isopropanol was added and the solution was evaporated water was added and the product was isolated by extraction with e This compound atent of trimethylbenzylammonium misiteate to give dilution with extraction with ether and crystallisation from the title compound go and 241 EXAMPLE 14 g o prepared as above in 100 methanolic potassium hydroxide was kept under nitrogen at for 24 hours After acidification and extraction with benzene the product was passed through a short column of basic eluting with benzene The factions were evaporated and the residue crystallised twice from to The combined mother liquors were evaporated and the residue crystallised twice from to give g o 240 insufficientOCRQuality
Claims (1)
1. CLAIMS A steroid compound of formula (I) where X is a hydroxymethylene, carbonyl or ketalised carbonyl group; and the hydrogen atoms H at positions 8, 9 and 14 and the ethyl group at position -13 on ring G are in' the trans- anti-trans configuration and the hydrogen atom H at position 10 is cis to the ethyl group, and the ) at position 17 on ring D designates that the side chain -X-CH-, is either cis or trans to the 13-ethyl group. 17P-Acetyl-i3p-ethyl-gon- h-3-one. - 17a-Acetyl-13p-eth'yl-gon- -en-3TO.ne. \' · " ' ' .j . . ' ' . ' · . · " ' i id compound of formula .(I) . where X is a hydroxymethylene, carbonyl or ketalised carbonyl group; I and the hydrogen atoms H at positions 8,9 and 1¼ and the ethyl group at position -13 in ring C are in the trans-anti-trans configuration and the hydrogen atom H at position 10 is cis_ to the ethyl group, particularly 17P-acetyl-13(5-ethyl~gon-½-en-3-one, . in whichs (a) a steroid compound of formula (II) X-50-fa in which one or both of X and Z are hydroxymethylene groups, any remaining X or Z group which is not such a group being a carbonyl group or in the case of X a protected, eng ketalised carbonyl group, the dotted lines signify an ethylenic bond terminating at the 5- position, the group at position 17 is in either configuration and the configurations at positions 8,9«13 and l are as defined above, is oxidised at one or both of the 3 and 20 positions5 (b) a steroid compound of formula (III) where X is a hydroxy methylene group, a carbonyl group or a protected, e.g a ketalised carbonyl group, Y is a carbonyl group in conjunction with an ethylenic bond terminating at the 5-position or a protected carbonyl group in conjunction with unsaturation in rings A and B indicated by the dotted lines such that it is hydrolysable to a ^,5- or 5(10)-ethylenic-3-ketone, one or both of X and Y being a protected carbonyl group, the group at positional? is in either configuration and the configurations at positions 8,9»13 and l are as defined above, cleatte is hydrolysed to «ap-pow the protecting group or groups at one or both of the 3 and 20 positions; (c) a steroid compound of formula (IV) (IV) 4- X~50~fa where the dotted lines signify the presence of an ethylenic bond at the 5(10) or 5i6~position, the group at position 17 is in either configuration and the configuration at positions 8,9,13 and Ik are as defined above, is isomerised to shift the ethylenic bond to the „5~positionj or (d) a steroid compound of formula (V) in which Hal is a halogen atom, preferably bromine or chlorine, in the a or β-configuration, the 5-hydrogen atom and the group at position 17 can be in either configuration and the configurations at positions 8,9?13 and Ik are as defined above, is dehydrohalogenated to introduce a bond? With, when necessary, oxidation of a hydroxymethylene group X to a carbonyl group, reaction of a carbonyl group X with a ketalising alcohol, hydrolysis of a protected e»g. ketalised carbonyl group X or reduction of a carbonyl group X to a hydroxy- methylene group and again where necessary dsomerisation of an ethylenic bond at the 5(10)- or 5,6-position to the ,5- position or of a 17 -acetyl side chain to a 17a~acetyl side chain., 5· A process according to Claim k in which the compound of formula III is a 3-enol ether, 3~enol-acylate, 3-enol-thioether, 3-ej.amine, 3-ketal, 3-thioketal, or 3- hemithioketal of a , - or 5(10)- ethylenic-3-ketone<> 6. A process according to Claim 5 in which the compound of formula III is a 3-alkoxy-2,5(l0)-diene<, X-50-fa A process according to Claim substantially as described herein and shown with reference to any one of Examples 80 A process according to Claim k substantially as described herein and shown with reference to any one of Examples 5 to » o A process according to Claim k substantially as described herein and shown with reference to any one of Examples 10 to 12« 10ο· A process according to Claim substantially as described herein and shown with reference to Example 13 or Example lk„ of the several formula given in Glain 1 llo A steroid compound/produced by a process according to any one of Claims to 100 17-acetyl-13/¾-ethyl-gon-4-en-3-one 12o A pharmaceutical composition comprising a j6 e»oid-eeapowa4 according to any one of Claims 1 to 3 an 11 in association with a pharmaceutically acceptable carriedo Dated this 18th day of December, 1966
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL2709066A IL27090A (en) | 1966-12-19 | 1966-12-19 | 17-acetyl-13beta-ethyl-gon-4-en-3-one derivatives and process for the manufacture thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL2709066A IL27090A (en) | 1966-12-19 | 1966-12-19 | 17-acetyl-13beta-ethyl-gon-4-en-3-one derivatives and process for the manufacture thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL27090A true IL27090A (en) | 1970-11-30 |
Family
ID=11044072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL2709066A IL27090A (en) | 1966-12-19 | 1966-12-19 | 17-acetyl-13beta-ethyl-gon-4-en-3-one derivatives and process for the manufacture thereof |
Country Status (1)
| Country | Link |
|---|---|
| IL (1) | IL27090A (en) |
-
1966
- 1966-12-19 IL IL2709066A patent/IL27090A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bagli et al. | Synthetic studies on C-19 oxygenated pregnanes | |
| Djerassi et al. | Steroidal Sapogenins. XXII. 1 Steroids. XXXIV. 2 Degradation of 11-Oxygenated Sapogenins. Synthesis of Allopregnane-3β, 11β-diol-20-one and Allopregnane-3β, 11α-diol-20-one | |
| US4044004A (en) | Total steroid synthesis employing substituted isoxazole derivatives | |
| JPS61106598A (en) | 24,25-dihydroxy-6-substituted-3 alpha,5-cyclo-5 alpha-cholestane derivative | |
| Eadon et al. | Mass spectrometry in structural and stereochemical problems. CCXI. Effect of structural variations on the electron impact-induced fragmentations of steroid hydrocarbons | |
| US3849402A (en) | 19-oxygenated and 19-nor delta8(14)-steroid compounds | |
| US3515719A (en) | 7-methyl-6,19-epoxy steroids of the androstane series | |
| IL27090A (en) | 17-acetyl-13beta-ethyl-gon-4-en-3-one derivatives and process for the manufacture thereof | |
| IL31973A (en) | 15beta,16beta-methylene pregnenes and their manufacture | |
| US3787394A (en) | 19-nor-7alpha-methyl or 19-nor-20-spirox-4,14-dien-3-one and 18-methyl derivatives thereof | |
| Dawidar et al. | Hydroxylation of⊿ 5-Steroids with N-Bromosuccinimide to 5α, 6β-Diols | |
| Cross et al. | Steroids. CCLVII. 1 5, 10-Disubstituted Estranes | |
| JPS60252494A (en) | Estrogen synthesis inhibitor | |
| Rakhit et al. | STEROIDS AND RELATED PRODUCTS: XXI. THE SYNTHESIS OF 17α-BROMO-6α-METHYLPROGESTERONE | |
| US3096350A (en) | 6, 16alpha-dimethyl-delta1, 4, 6-pregnatriene-17alpha-ol-3, 20-dione and esters thereof | |
| US3083199A (en) | delta3-5alpha-steroids and 3alpha-hydroxy-5alpha-steroids and the preparation thereof | |
| IL32699A (en) | 6-substituted-13-polycarbonalkyl-18,19 dinorpregn-4-en-3-ones,their preparation and pharmaceutical compositions containing them | |
| US3758509A (en) | Aryl ketals of polycyclic oxo compounds and processes | |
| US2934532A (en) | Delta 5-11, 20-diketo-pregnene 3-ketals and process | |
| Johns | Synthesis and reactions of 5. alpha., 8-epidioxyandrost-6-enes | |
| US2864818A (en) | belta5-11, 16, 20-triketo-pregnene 3-ketals and process | |
| Hesse et al. | Substitution at Unactivated Carbon. The Synthesis of 18-and 19-Substituted Derivatives of 11β-Hydroxyprogesterone*, 1, 2 | |
| US2864819A (en) | belta5, 16-11, 20-diketo-16-(organic sulfonoxy)-pregnadiene-3-ketals and process | |
| US2884419A (en) | Chemical compounds and processes for preparing the same | |
| US3717663A (en) | 9-alpha-methyl steroids |